CHICAGO – "It's remarkable to me how the pediatric oncology community manages to continue to make great strides by using old drugs in new ways," American Society of Oncology (ASCO) Chief Medical Officer Richard Schilsky said during the group's meeting, as he spoke about the first advance in 30 years in rhabdomyosarcoma (RMS), a rare cancer of the muscle tissue that strikes children.